Please login to the form below

Not currently logged in
Email:
Password:

Entresto

This page shows the latest Entresto news and features for those working in and with pharma, biotech and healthcare.

Novartis negotiates ex-US rights to Spark gene therapy

Novartis negotiates ex-US rights to Spark gene therapy

The gains were driven by strong performances from new immunotherapy Cosentyx (secukinumab), which breached the $2bn sales threshold for the year, as well as heart failure therapy Entresto (sacubitril and valsartan)

Latest news

More from news
Approximately 22 fully matching, plus 20 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics